When a saboteur laced Tylenol capsules with cyanide in 1982, killing seven people in the Chicago area, Johnson & Johnson’s quick recall of millions of capsules, free replacement medicines and frequent updates set the standard for public relations in a crisis.
But on April 30, the company again faced a recall, this time of more than 136 million bottles of pediatric Tylenol, Motrin, Benadryl and Zyrtec due to manufacturing problems. Suddenly, the company’s halo is showing some tarnish. Investigators haven’t linked the defects in the medication to any health problems, but the Food and Drug Administration (FDA) said the division of the company responsible for quality control at the Pennsylvania-based plant, McNeil Consumer Healthcare, had a pattern of violations and delayed reporting problems to the agency.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
